Regulus Therapeutics Inc. Stock News

After losing some value lately, a hammer chart pattern has been formed for Regulus (RGLS), indicating that the stock has found support. This, combined with an upward trend in earnings estimate revisio

Regulus Therapeutics Inc. (NASDAQ:RGLS) has a beta value of 2.01 and has seen 1.38 million shares traded in the last trading session. The company, currently valued at $32.57M, closed the last trade at $0.36 per share which meant it gained $0.02 on the day or 5.83% during that session. The RGLS stock price is -544.44% An In-Depth Look At Regulus Therapeutics Inc. (RGLS) Read More »

Regulus Therapeutics Inc. (NASDAQ:RGLS) with the stream of -4.91% also noticed, India 1847 Goedeker Inc. (AMEX:GOED) encountered a rapid change of -3.35% in the last hour of Fridays trading session. The post Remarkable Stock in Review: Regulus Therapeutics Inc. (NASDAQ:RGLS), 1847 Goedeker Inc. (AMEX:GOED) appeared first on Stocks Equity .

Zacks Investment Research upgraded shares of Regulus Therapeutics (NASDAQ:RGLS) from a sell rating to a hold rating in a report published on Wednesday morning, Zacks.com reports. According to Zacks, Regulus Therapeutics Inc. is a biopharmaceutical company focused on discovering and developing drugs that target microRNAs, called microRNA therapeutics. The Companys products aim to treat or [] The post Regulus Therapeutics (NASDAQ:RGLS) Upgraded by Zacks Investment Research to Hold appeared first on ETF Daily News .

Zacks Investment Research upgraded shares of Regulus Therapeutics (NASDAQ:RGLS) from a sell rating to a hold rating in a research note issued to investors on Wednesday morning, Zacks.com reports. According to Zacks, Regulus Therapeutics Inc. is a biopharmaceutical company focused on discovering and developing drugs that target microRNAs, called microRNA therapeutics. The Companys products aim []

Regulus Therapeutics Inc. (NASDAQ:RGLS) with the stream of -3.25% also noticed, India B2Gold Corp. (AMEX:BTG) encountered a rapid change of -1.91% in the last hour of Tuesdays trading session. Regulus The post Traders should take notice on: Regulus Therapeutics Inc. (NASDAQ:RGLS), B2Gold Corp. (AMEX:BTG) appeared first on Stocks Equity .

State Street Corp bought a new stake in Regulus Therapeutics Inc. (NASDAQ:RGLS) in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm bought 176,494 shares of the biopharmaceutical companys stock, valued at approximately $144,000. State Street Corp owned approximately 0.20% of Regulus Therapeutics [] The post State Street Corp Buys New Shares in Regulus Therapeutics Inc. (NASDAQ:RGLS) appeared first on ETF Daily News .

In the last trading session, 1.36 million Regulus Therapeutics Inc. (NASDAQ:RGLS) shares changed hands as the companys beta touched 2.01. With the companys per share price at $0.34 changed hands at -$0.03 or -6.85% during last session, the market valuation stood at $31.80M. RGLSs last price was a discount, traded about -582.35% off its 52-week Why To Invest In Regulus Therapeutics Inc. (NASDAQ: RGLS) Stock? Read More »

SAN DIEGO , Dec. 1, 2021 /PRNewswire/ -- Regulus Therapeutics Inc. (Nasdaq: RGLS), a biopharmaceutical company focused on the discovery and development of innovative medicines targeting microRNAs (the "Company" or "Regulus"), today announced a presentation at the first annual Rare & Genetic

Regulus Therapeutics (NASDAQ:RGLS) and OncoSec Medical (NASDAQ:ONCS) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, valuation, risk, analyst recommendations, earnings, dividends and profitability. Insider & Institutional Ownership 26.3% of Regulus Therapeutics shares are owned by institutional investors. Comparatively, []

Regulus Therapeutics Inc. (RGLS) with the stream of -4.87% also noticed, India PetVivo Holdings, Inc. Warrant (PETVW) encountered a rapid change of 4.35% in the last hour of Mondays trading The post Have a grip on this: Regulus Therapeutics Inc. (NASDAQ:RGLS), PetVivo Holdings, Inc. Warrant (NASDAQ:PETVW) appeared first on Stocks Equity .

Regulus Therapeutics Inc. (RGLS) with the stream of 4.85% also noticed, India ECMOHO Limited (MOHO) encountered a rapid change of 0.46% in the last hour of trading session. Regulus Therapeutics The post Traders shouldnt Staggering on this: Regulus Therapeutics Inc. (NASDAQ:RGLS), ECMOHO Limited (NASDAQ:MOHO) appeared first on Stocks Equity .

Geode Capital Management LLC increased its stake in shares of Regulus Therapeutics Inc. (NASDAQ:RGLS) by 54.3% in the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 589,196 shares of the biopharmaceutical companys stock after purchasing an additional 207,304 shares during the []

Virtu Financial LLC purchased a new stake in shares of Regulus Therapeutics Inc. (NASDAQ:RGLS) during the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor purchased 79,193 shares of the biopharmaceutical companys stock, valued at approximately $64,000. Several other large investors have also recently []

Regulus Therapeutics (NASDAQ:RGLS) and OncoSec Medical (NASDAQ:ONCS) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, valuation, risk, profitability, dividends, earnings and analyst recommendations. Insider & Institutional Ownership 26.3% of Regulus Therapeutics shares are held by institutional investors. Comparatively, []